Anti-Inflammatory and Analgesic Effects of Highly Selective Microsomal Prostaglandin E2 Synthase-1 (mPGES-1) Inhibitors
UKnowledge (University of Kentucky) · 15.05.2023
DOI: 10.13023/etd.2023.229 ↗Kurz gefasst
Fachartikel in der Zeitschrift UKnowledge (University of Kentucky), erschienen am 15.05.2023. Verfasst von Madeline J. Stewart.
Abstract (Originalsprache)
Lipid messenger prostaglandin E2 (PGE2) is a prostanoid that plays a key role in the generation of the inflammatory response. Currently available non-steroid anti-inflammatory drugs (NSAIDs) inhibit cyclooxygenase (COX)-1 and/or COX-2, all with significant cardiovascular, cerebrovascular, and gastrointestinal risks that have limited their utilization. Microsomal PGE2 synthase 1 (mPGES-1), an inducible enzyme responsible for overproduction of PGE2, may be a more promising target for a new type of anti-inflammatory drug without the adverse effects associated with the COX-1/2 inhibition. There have been extensive efforts to design and discover inhibitors targeting mPGES-1. Unfortunately, within the previously reported potent human mPGES-1 inhibitors, few have also been identified as potent inhibitors of mouse or rat mPGES-1, which prevents the use of well-established mouse or rat models of inflammation and pain in preclinical drug development. In a recently published study, we were able to design and discover a novel compound, denoted as UK4b, capable of potently inhibiting both human mPGES-1 (IC50=33 nM) and mouse mPGES-1 (IC50=157 nM). Additionally, our lab has designed and discovered another potent mPGES-1 inhibitor, KD001, and has computationally identified an FDA-approved drug, ceftriaxone, as a potent mPGES-1 inhibitor. In this dissertation, we demonstrate that UK4b, KD001, and ceftriaxone all have the desired potent anti-inflammatory and analgesic effects against post-operative pain in wild-type mice, adjuvant-induced knee joint arthritis in wild-type rats, and carrageenan-induced paw edema and hyperalgesia.
Schlagwörter
Zitieren
APA
Stewart, M. J. (2023). Anti-Inflammatory and Analgesic Effects of Highly Selective Microsomal Prostaglandin E2 Synthase-1 (mPGES-1) Inhibitors. UKnowledge (University of Kentucky). https://doi.org/10.13023/etd.2023.229
Vancouver
Stewart MJ. Anti-Inflammatory and Analgesic Effects of Highly Selective Microsomal Prostaglandin E2 Synthase-1 (mPGES-1) Inhibitors. UKnowledge (University of Kentucky). 2023. doi:10.13023/etd.2023.229
BibTeX
@article{Stewart2023,
author = {Stewart, Madeline J.},
title = {Anti-Inflammatory and Analgesic Effects of Highly Selective Microsomal Prostaglandin E2 Synthase-1 (mPGES-1) Inhibitors},
journal = {UKnowledge (University of Kentucky)},
year = {2023},
doi = {10.13023/etd.2023.229}
}
EUVIMED